Skip to main content
Journal of Infection Prevention logoLink to Journal of Infection Prevention
. 2018 May 19;19(5):236–239. doi: 10.1177/1757177418765634

Screening for Middle East respiratory syndrome coronavirus among febrile Indonesian Hajj pilgrims: A study on 28,197 returning pilgrims

M Amin 1,, A Bakhtiar 1, M Subarjo 1, EB Aksono 2, P Widiyanti 3, K Shimizu 4, Y Mori 4
PMCID: PMC6109871  PMID: 30159042

Abstract

There were 211,000 Indonesian Hajj pilgrims going to Mecca through 11 main airports in 2015 who were at risk of contracting the Middle East respiratory syndrome coronavirus (MERS-CoV). We aimed to find out whether there was any occurrence of MERS-CoV by performing screening on 28,197 returning pilgrims. Those with a body temperature of > 38 °C and respiratory symptoms were sent to the airport clinic to have an oropharyngeal swab and a bacterial culture. Fifteen pilgrims had fever (> 38 °C) accompanied by respiratory symptoms; of these, 12 patients were diagnosed with upper and lower respiratory tract infections and three patients with pneumonia. However, none of them were found to be infected with MERS-CoV. The bacterial cultures showed evidence of normal flora growth.

Keywords: MERS-CoV, pilgrims, screening, Indonesia

Introduction

Hajj (pilgrimage) is a mandatory religious ritual required by all able Muslims once in their lifetime. The pilgrimage is considered the largest annual religious gathering with up to three million participants from around the world. The pilgrims should perform a series of physically demanding religious rituals in about 5–6 days in the city of Mecca and surrounding places that could potentially affect their health (Hashim et al., 2016), in addition to unpredictable weather conditions.

Since 2012, the Middle East respiratory syndrome coronavirus (MERS-CoV) has become endemic in the Kingdom of Saudi Arabia (KSA) and other Arabian Peninsula countries. To date, there have been 1905 of reported MERS-CoV cases with 677 deaths from 27 countries (World Health Organization, 2017). MERS-CoV symptoms range from mild influenza-like symptoms to severe acute respiratory disease (Memish et al., 2013). Multiple outbreaks have been reported in hospitals and community settings with possible human transmission (Assiri et al., 2013; Oboho et al., 2015), yet the virus reservoirs and disease transmission are not fully understood. In confirmed cases of the infection, the mortality rate can be as high as 45% with chronic morbidities or existing diseases as the prominent risk characteristics (Center for Disease Control and Prevention, 2013; Cho et al., 2016; Perlman, 2013). Moreover, physical exhaustion of pilgrims and crowded conditions may be related to the outbreaks of this virus.

Indonesia contributes to the annual religious gathering as a country with the highest number of Hajj pilgrims with up to 211,000 people attending annually. They depart from 11 official airports as embarkation points, one of which is Juanda airport in Surabaya, East Java. Surabaya port also represents one of the biggest embarkation points in the country, with nearly 30,000 pilgrims departing in 2015. Previous reports suggested that > 50% of the pilgrims departing from Surabaya are at high risk of contracting infectious diseases (Kantor Kesehatan Pelabuhan Surabaya, 2013). Therefore, early detection in pilgrims is an important preventive action to tackle the spread of MERS-CoV to their communities upon completing the pilgrimage. This study aimed to screen all pilgrims returning to Indonesia at the Surabaya debarkation point in the 2015 Hajj season.

Methods

Ethics

This study has been reviewed and approved by local ethics commissions. All investigated participants were also provided with written informed consent prior to investigation.

Screening procedures

We administered the screening protocol on all pilgrims arriving at the Surabaya debarkation point during the 2015 Hajj season. Every returning pilgrim at the airport had to pass through a thermal detector upon arrival. Pilgrims with body temperature of > 38 °C accompanied by respiratory symptoms such as cough and dyspnoea were quarantined, had their details recorded and an oropharyngeal swab was taken by trained personnel. Should there be an acute condition, pilgrims were directly hospitalised at the designated hospital, while those with mild symptoms could return home and for follow-up after the laboratory tests were completed. For those with body temperature < 38 °C, a report had to be made to the nearest primary healthcare centre or hospital if they experienced a body temperature increase (> 38 °C) which was accompanied by respiratory symptoms within ten days of their return to the country. In this study, a thermal body scanner was tested and calibrated before use.

Case definitions

Early diagnosis was made based on clinical presentation upon case detection. A MERS-CoV case was defined if the real-time polymerase chain reaction (RT-PCR) test of the pharyngeal swab was positive for MERS-CoV. Other bacterial infections were investigated based on the pharyngeal swab culture.

Laboratory test for MERS-CoV

The MERS-CoV from the oropharyngeal swab specimen was tested using the RT-PCR technique by means of RNA extraction from the specimen of oropharyngeal swab. The benefit of RT-PCR testing has been described elsewhere (Wacker and Godard, 2005). The bacterial culture of the swab was conducted at an accredited laboratory of microbiology in Surabaya.

In the RT-PCR technique, extraction of RNA from swab samples was performed using a Qiaamp MinElute Virus Spin Kit (Qiagen, Tokyo, Japan) following the manufacturer’s manual at the Biosafety Level 3 laboratory facility. Examination for the presence of the MERS-CoV genomes in the swab was carried out by one-step TaqMan RT-PCR using a QuantiTect Probe RT-PCR Kit (Qiagen, Tokyo, Japan). The reaction mixture was made up with 5 µL of template RNA, with each primer at a final concentration of 0.6 gM, probe 0.1 µM and QuantiTect probe RT-PCR mix. The mixture was then subjected to a one-step assay with an ABI model 7300 Instrument by using the following amplification conditions: step 1 = RT for 30 min at 50 °C; step 2 = 15 min at 95 °C to activate 7aq polymerase; and step 3 = 45 cycles of 15 s at 94 °C and 75 s at 56 °C. Primers and TaqMan probes were designed according to Corman et al. (2012). Synthetic RNAs of upE and Orfla sequences were used as a positive control with permission (National Institute of Health, 2015).

Results

There were 28,197 Hajj pilgrims returning to Indonesia through Juanda airport between October and December 2015 who passed through the body thermal detector. Of these, 15 pilgrims were detected to have a body temperature > 38 °C with respiratory symptoms such as cough, flu and sore throat, and thus were further investigated. The age range of those investigated was 40–80 years (8 men, 7 women).

Of the 15 pilgrims investigated, 12 were clinically diagnosed with upper respiratory tract infection, while three others were diagnosed with pneumonia. Those with pneumonia were sent directly to the local hospital while the remaining 12 pilgrims were sent home. Three patients had a co-morbidity of hypertension and one pilgrim had both hypertension and coronary heart disease.

The RT-PCR test showed no evidence of MERS-CoV infection among 15 oropharyngeal swab samples. Bacteria were detected in nine swab cultures. Detailed findings are shown in Table 1.

Table 1.

Case finding of 15 pilgrims with fever.

No. Sex Age (years) Co-morbidities Diagnosis PCR result of oropharyngeal swab (MERS-CoV) Oropharyngeal swab bacterial culture
1 Male 55 Hypertension URTI Negative No bacterial growth
2 Male 61 Hypertension URTI Negative No bacterial growth
3 Female 40 - URTI Negative No bacterial growth
4 Male 83 Hypertension, heart disease Pneumonia Negative Corynebacterium urealyticum
5 Female 66 - URTI Negative Staphylococcus epidermidis
6 Male 41 - URTI Negative Staphylococcus aureus
7 Male 62 - LRTI Negative No bacterial growth
8 Male 63 Hypertension Acute pharyngitis Negative No bacterial growth
9 Female 48 - URTI Negative Corynebacterium ulcerans
10 Female 71 - LRTI Negative Corynebacterium ulcerans
11 Male 46 - URTI Negative Corynebacterium ulcerans
12 Male 40 - URTI Negative No bacterial growth
13 Female 78 - URTI Negative Corybacterium ulcerans
14 Female 65 - Pneumonia Negative Corynebacterium matruchotii
15 Female 86 - Pneumonia with suspected MERS-CoV Negative Streptococcus viridans

URTI, upper respiratory tract infection; LRTI, lower respiratory tract infection; MERS-CoV, Middle East respiratory syndrome coronavirus.

Discussion

The objective of this study was to detect MERS CoV-infected Hajj pilgrims at Surabaya debarkation point, who could potentially carry infection to Indonesia. This was conducted on all Hajj pilgrims arriving at the debarkation point of Surabaya airport, 28,197 pilgrims in total.

In this study, 15 Hajj pilgrims were found to have fever (body temperature > 38°C) accompanied by respiratory symptoms. The PCR test from oropharyngeal swab specimens did not reveal the presence of MERS-CoV in the tested samples. The pilgrims have been instructed by the physicians to report to the MERS-CoV team if they had fever within ten days of their return. None of them reported symptoms within the time frame.

The result of this study is similar to an early detection of MERS-CoV done in 2012 by Gautret et al. (2013) on French Hajj pilgrims using the RT-PCR method with no evidence of MERS-CoV infection detected. Another sero-survey of MERS-CoV was done in Germany on 123 people with negative result (Buchholz et al., 2013).

All of the patients investigated had fever captured by the thermal detector. The thermal detector may have a sensitivity of up to 90% in detecting body temperature (Priest et al., 2011). However, there is also a varying degree of sensitivity according to the site of the body, with the eyes and forehead having the highest correlation to the actual body temperature (Ng et al., 2004). In addition, thermal detection of body temperature may be affected by ambient air temperature and location of measurement (Liu et al., 2004). Antipyretic use before scanning may also yield a false-negative result.

The bacteria recovered from the swabs of pyrexial patients predominantly reflected normal flora. This was in line with a study performed at Jeddah airport on pilgrims from 13 countries where virus and bacteria were the predominant pathogens (Memish et al., 2015). Tuberculosis has also been identified among patients admitted to hospitals during the Hajj (Al-Tawfiq et al., 2013). However, given the incubation time of the disease, it is challenging to identify such cases in a rapid survey during short period of time.

Study limitations

A recent meta-analysis suggested most respiratory symptoms from returning of Hajj pilgrim was caused by viral infection other than MERS or SARS coronavirus (Gautret et al., 2016). We did not perform specific investigation of other common respiratory virus and thus limit this study in explaining etiological aspects of the investigated cases.

The method of using the thermal body detector may have some limitations in detecting MERS-CoV as the disease may not always present with fever. In addition, pilgrims could have taken an antipyretic before arrival. Despite those limitations, the study protocol also includes a subsequent monitoring by means of pilgrims’ self-report upon ten days of arrival involving local health authorities and public healthcare centres. This may reduce the risk of missing MERS-CoV, especially in those pilgrims without fever.

Conclusion

In this study, there was no evidence of MERS-CoV infection among 28,197 Hajj pilgrims returning at Surabaya debarkation point in 2015 presenting with fever. Given the large number of Indonesian Hajj pilgrims annually, constant surveillance involving all debarkation points is needed for early prevention of MERS-CoV spread.

Footnotes

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The author(s) received no financial support for the research, authorship, and/or publication of this article.

Peer review statement: Not commissioned; blind peer-reviewed.

References

  1. Al-Tawfiq JA, Zumla A, Memish ZA. (2013) Respiratory tract infections during the annual Hajj: potential risks and mitigation strategies. Current Opinion in Pulmonary Medicine 19: 192–197. [DOI] [PubMed] [Google Scholar]
  2. Assiri A, McGeer A, Perl TM, Price CS, Al Rabeeah AA, Cummings DA, Alabdullatif ZN, Assad M, Almulhim A, Makhdoom H, Madani H, Alhakeem R, Al-Tawfiq JA, Cotten M, Watson SJ, Kellam P, Zumla AI, Memish ZA. and KSA MERS-CoV Investiation Team. (2013) Hospital outbreak of Middle East respiratory syndrome coronavirus. New England Journal of Medicine 369: 407–416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Buchholz U, Muller MA, Nitsche A, Sanewski A, Wevering N, Bauer-Balci T, Bonin F, Drosten C, Schweiger B, Wolff T, Muth D, Meyer B, Buda S, Krause G, Schaade L, Haas W. (2013) Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012. Euro Surveillance 18: 20406. [PubMed] [Google Scholar]
  4. Center for Disease Control and Prevention (CDC). (2013) Updated Information on the Epidemiology of Middle East Respiratory Syndrome Corona virus (MERS- CoV) Infection and Guidance for the Public, Clinicians, and Public Health Authorities, 2012–2013. Morbidity and Mortality Weekly Report 62: 793–796. [PMC free article] [PubMed] [Google Scholar]
  5. Cho SY, Kang JM, Ha YE, Park GE, Lee JY, Ko JH, Lee JY, Kim JM, Kang CI, Jo IJ, Ryu JG, Choi JR, Kim S, Huh HJ, Ki CS, Kang ES, Peck KR, Dhong HJ, Song JH, Chung DR, Kim YJ. (2016) MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study. Lancet 388: 994–1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Corman VM, Eckerle I, Bleicker T, Zaki A, Landt O, Eschbach-Bludau M, van Boheemen S, Gopal R, Ballhause M, Bestebroer TM, Muth D, Muller MA, Drexler JF, Zambon M, Osterhaus AD, Fouchier RM, Drosten C. (2012) Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveillance 17: 20285. [DOI] [PubMed] [Google Scholar]
  7. Gautret P, Benkouiten S, Al-Tawfiq JA, Memish ZA. (2016) Hajj-associated viral respiratory infections: A systematic review. Travel Medicine and Infectious Disease 14: 92–109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gautret P, Charrel R, Belhouchat K, Drali T, Benkouiten S, Nougairede A, Zandotti C, Memish ZA, al Masri M, Gaillard C, Brouqui P, Parola P. (2013) Lack of nasal carriage of novel corona virus (HCoV-EMC) in French Hajj pilgrims returning from the Hajj 2012, despite a high rate of respiratory symptoms. Clinical Microbiology and Infection 19: E315–317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hashim S, Ayub ZN, Mohamed Z, Hasan H, Harun A, Ismail N, Rahman ZA, Suraiya S, Naing NN, Aziz AA. (2016) The prevalence and preventive measures of the respiratory illness among Malaysian pilgrims in 2013 Hajj season. Journal of Travel Medicine 23: tav019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kantor Kesehatan Pelabuhan Surabaya (Surabaya Port Heatlh Authority). (2013) Laporan Siskohat Kesehatan Embarkasi Haji Surabaya tahun 2013. Surabaya, Indonesia: Kantor Kesehatan Pelabuhan Klas I Surabaya. [Google Scholar]
  11. Liu CC, Chang RE, Chang WC. (2004) Limitations of forehead infrared body temperature detection for fever screening for severe acute respiratory syndrome. Infect Control Hosp Epidemiol 25: 1109-1111. [DOI] [PubMed] [Google Scholar]
  12. Memish ZA, Assiri A, Turkestani A, Yezli S, Al Masri M, Charrel R, Drali T, Gaudart J, Edouard S, Parola P, Gautret P. (2015) Mass gathering and globalization of respiratory pathogens during the 2013 Hajj. Clinical Microbiology and Infection 21: 571 e571–578. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Memish ZA, Zumla A, Al-Tawfiq JA. (2013) How great is the risk of Middle East respiratory syndrome coronavirus to the global population? Expert Review of Anti-Infective Therapy 11: 979–981. [DOI] [PubMed] [Google Scholar]
  14. National Institute of Health (NIH). (2015) Middle East Respiratory Syndrome. NIH, Japan: Available at: http://www.nih.go.jp/niid/ja/diseases/alphabet/mers.html. [Google Scholar]
  15. Ng EY, Kaw GJ, Chang WM. (2004) Analysis of IR thermal imager for mass blind fever screening. Microvasc Res 68: 104-109. [DOI] [PubMed] [Google Scholar]
  16. Oboho IK, Tomczyk SM, Al-Asmari AM, Banjar AA, Al-Mugti H, Aloraini MS, Alkhaldi KZ, Almohammadi EL, Alraddadi BM, Gerber SI, Swerdlow DL, Watson JT, Madani TA. (2015) 2014 MERS-CoV outbreak in Jeddah–a link to health care facilities. New England Journal of Medicine 372: 846–854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Perlman S. (2013) The Middle East respiratory syndrome–how worried should we be? MBio 4: e00531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Priest PC, Duncan AR, Jennings LC, et al. (2011) Thermal image scanning for influenza border screening: results of an airport screening study. PLoS One 6: e14490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wacker MJ, Godard MP. (2005) Analysis of one-step and two-step real-time RT-PCR using SuperScript III. Journal of Biomolecular Techniques 16: 266–271. [PMC free article] [PubMed] [Google Scholar]
  20. World Health Organization. (2017) Middle East respiratory syndrome coronavirus (MERS-CoV). Geneva: WHO; Available at: http://www.who.int/emergencies/mers-cov/en/. [Google Scholar]

Articles from Journal of Infection Prevention are provided here courtesy of SAGE Publications

RESOURCES